MICHAEL JOHNSON to Prescription Drugs
This is a "connection" page, showing publications MICHAEL JOHNSON has written about Prescription Drugs.
Connection Strength
0.854
-
Good research practices for comparative effectiveness research: defining, reporting and interpreting nonrandomized studies of treatment effects using secondary data sources: the ISPOR Good Research Practices for Retrospective Database Analysis Task Force Report--Part I. Value Health. 2009 Nov-Dec; 12(8):1044-52.
Score: 0.310
-
Patient-reported outcomes in light of supportive medications in treatment-na?ve lung cancer patients. Support Care Cancer. 2020 Apr; 28(4):1809-1816.
Score: 0.153
-
Association between industry payments and prescribing costly medications: an observational study using open payments and medicare part D data. BMC Health Serv Res. 2018 04 02; 18(1):236.
Score: 0.140
-
The Prevalence of and Factors Associated With Receiving Concurrent Controlled Substance Prescriptions. Subst Use Misuse. 2017 Oct 15; 52(12):1639-1645.
Score: 0.132
-
Development and Validation of the RxDx-Dementia Risk Index to Predict Dementia in Patients with Type 2 Diabetes and Hypertension. J Alzheimers Dis. 2016; 49(2):423-32.
Score: 0.120